돌발성 난청 환자에서 고실내 스테로이드 주입술 시기에 따른 청력 개선 효과
Hearing Outcome According to the Timing of Intratympanic Dexamethasone Injection in Idiopathic Sudden Sensorineural Hearing Loss
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Background and Objectives Oral systemic steroids are the most commonly accepted treatment for idiopathic sudden sensorineural hearing loss (SSNHL) despite pathophysiological uncertainty. Recently, intratympanic dexamethasone (ITD) has been proposed as an effective, alternative method for patients in whom oral steroids either fail to respond or are contraindicated. The authors compared the efficacy of ITD according to the duration of hearing loss prior to first dose of ITD. Subjects and Method We retrospectively reviewed the medical records and audiologic data of 86 SSNHL patients who received ITD from May 2009 to April 2012. Injections were repeated 5 times for 2 weeks and the favorable recovery was defined as complete or partial recovery using Siegel’s criteria. We compared the hearing outcomes between pre-ITD and post-ITD with respect to the duration of hearing loss. Results The mean pure-tone audiograms before and after ITD were 57.91±25.52 dB and 50.81±24.28 dB (p＜0.01), respectively. According to Siegel’s criteria, the overall rate of hearing improvement after ITD was 22.1% (19/86). Favorable hearing recovery was observed in 8 of 18 (44.4%) patients within 10 days, 7 out of 41 (17.1%) between 10 days and 20 days, 2 of 18 (11.1%) between 20 days and 30 days, 2 of 7 (28.6%) over 30 days. Conclusion ITD is a useful method as primary or salvage treatment of SSNHL. The results of this study suggest that early ITD after hearing loss increase the probability of hearing recovery.
Abstract
Background and Objectives Oral systemic steroids are the most commonly accepted treatment for idiopathic sudden sensorineural hearing loss (SSNHL) despite pathophysiological uncertainty. Recently, intratympanic dexamethasone (ITD) has been proposed as an effective, alternative method for patients in whom oral steroids either fail to respond or are contraindicated. The authors compared the efficacy of ITD according to the duration of hearing loss prior to first dose of ITD. Subjects and Method We retrospectively reviewed the medical records and audiologic data of 86 SSNHL patients who received ITD from May 2009 to April 2012. Injections were repeated 5 times for 2 weeks and the favorable recovery was defined as complete or partial recovery using Siegel’s criteria. We compared the hearing outcomes between pre-ITD and post-ITD with respect to the duration of hearing loss. Results The mean pure-tone audiograms before and after ITD were 57.91±25.52 dB and 50.81±24.28 dB (p＜0.01), respectively. According to Siegel’s criteria, the overall rate of hearing improvement after ITD was 22.1% (19/86). Favorable hearing recovery was observed in 8 of 18 (44.4%) patients within 10 days, 7 out of 41 (17.1%) between 10 days and 20 days, 2 of 18 (11.1%) between 20 days and 30 days, 2 of 7 (28.6%) over 30 days. Conclusion ITD is a useful method as primary or salvage treatment of SSNHL. The results of this study suggest that early ITD after hearing loss increase the probability of hearing recovery.
참고문헌 (14)
- Wilson WR, "The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study", Arch Otolaryngol, 106(12), pp.772~776 (1980)
- Wei BP, "Steroids for idiopathic sudden sensorineural hearing loss", Cochrane Database Syst Rev, (1), pp.CD003998~ (2006)
- Conlin AE, "Treatment of sudden sensorineural hearing loss: I. A systematic review", Arch Otolaryngol Head Neck Surg, 133(6), pp.573~581 (2007)
- Spear SA, "Intratympanic steroids for sudden sensorineural hearing loss: a systematic review", Otolaryngol Head Neck Surg, 145(4), pp.534~543 (2011)
- Wilson WR, "Viral and epidemiologic studies of idiopathic sudden hearing loss", Otolaryngol Head Neck Surg, 91(6), pp.653~658 (1983)
- Gussen R, "Sudden deafnfess of vascular origin: a human temporal bone study", Ann Otol Rhinol Laryngol, 85(1 Pt 1), pp.94~100 (1976)
- Coelho DH, "Variability in the management of idiopathic sudden sensorineural hearing loss", Otolaryngol Head Neck Surg, 145(5), pp.813~817 (2011)
- Silverstein H, "Intratympanic steroid treatment of inner ear disease and tinnitus (preliminary report)", Ear Nose Throat J, 75(8), pp.468~476 (1996)
- Wu HP, "Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study", Otol Neurotol, 32(5), pp.774~779 (2011)
- Belhassen S, "Pain assessment of the intratympanic injections: a prospective comparative study", Eur Arch Otorhinolaryngol, 269(12), pp.2467~2473 (2012)
- Ho HG, "Effectiveness of intratympanic dexamethasone injection in sudden-deafness patients as salvage treatment", Laryngoscope, 114(7), pp.1184~1189 (2004)
- Ahn JH, "Therapeutic effectiveness over time of intratympanic dexamethasone as salvage treatment of sudden deafness", Acta Otolaryngol, 128(2), pp.128~131 (2008)
- Park MK, "Simultaneous versus subsequent intratympanic dexamethasone for idiopathic sudden sensorineural hearing loss", Otolaryngol Head Neck Surg, 145(6), pp.1016~1021 (2011)
- Ortmann AJ, "Sudden sensorineural hearing loss and delayed complete sudden spontaneous recovery", J Am Acad Audiol, 23(4), pp.249~255 (2012)